The Recall Desk
SevereFDA (Drugs)·D-1600-2020·Announced 2020-09-23

RLC Labs Recalls Nature-Throid Tablets Due to CGMP Deviations

RLC Labs Inc. is recalling Nature-Throid tablets due to Current Good Manufacturing Practice (CGMP) deviations. The products were manufactured under conditions found to be subpotent.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II and involves a subpotent medication, which poses a significant risk of treatment failure for patients relying on thyroid hormone replacement.

Plain-English summary

RLC Labs Inc. is voluntarily recalling Nature-Throid, Thyroid USP tablets. The recall is due to Current Good Manufacturing Practice (CGMP) deviations, specifically because the products were manufactured under the same conditions as those found to be subpotent.

The affected product is Nature-Throid, Thyroid USP [liothyronine (T3) 13.5 mcg and levothyroxine (T4) 57 mcg], 1.5 Grain (97.5 mg) Tablets. The recall includes 30-count, 60-count, 90-count, 100-count, and 1,000-count bottles. All lots with expiry dates between 10/2020 and 07/2023 are affected. The products were distributed nationwide in the United States.

Consumers should stop using the recalled products and contact their healthcare provider or pharmacist for guidance on alternative treatment options. The recall is classified as FDA Class II.

The recalled product

Product
Nature-Throid, Thyroid USP [liothyronine (T3) 13.5 mcg and levothyroxine (T4) 57 mcg], 1.5 Grain (97.5 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3305-4; b) 60-count bottles, NDC 64727-3305-5; c) 90-count bottles, NDC 64727-3305-6; d) 100-count bottles, NDC 64727-33
Manufacturer
RLC Labs Inc.
Category
Drug — Thyroid Hormone
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots with expiry between 10/2020-07/2023

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 24 recalled by RLC Labs Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 24 products in this recall →

Related recalls

Same manufacturer · RLC Labs Inc.

See all →

Same hazard · subpotency

See all →